SEC Form 4 · accession 0001209191-16-135834
GLOBUS MEDICAL INC · GMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
A Brett Murphy
Officer — Group President, Commerical Op
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001237831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 4, 2016 | M | 74,700 | $2.93 | A | 190,917 | D | |
| Class A Common StockF1 | Aug 4, 2016 | S | 74,700 | $23.3606 | D | 116,217 | D | |
| Class A Common Stock | Aug 5, 2016 | M | 32,992 | $2.93 | A | 149,209 | D | |
| Class A Common StockF2 | Aug 5, 2016 | S | 32,992 | $23.3936 | D | 116,217 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $2.93 | Aug 4, 2016 | M | 74,700 | D | — | Nov 1, 2016 | Class A Common Stock | 74,700 | 32,992 | D |
| Stock Option (Right to Buy Class A Common Stock)F3 | $2.93 | Aug 5, 2016 | M | 32,992 | D | — | Nov 1, 2016 | Class A Common Stock | 32,992 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.275 to $23.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.345 to $23.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4
- F3These options were granted on November 1, 2006, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on November 1, 2007, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.